LAS VEGAS, May 15, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that the United States patent, Title: Peripheral-Type Benzodiazepine Receptor: A tool for detection, diagnosis, prognosis, and treatment of cancer was formally allowed on April 9, 2007. U.S. Patent Application Serial Number: 09/047,652.
